Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?
until further notice
SourceEuropean Archives of Oto-Rhino-Laryngology, 273, 10, (2016), pp. 2877-94
Article / Letter to editor
Display more detailsDisplay less details
European Archives of Oto-Rhino-Laryngology
SubjectRadboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV-) OPC. This review summarizes and discusses several of the controversies regarding the management of HPV+ OPC, including the mechanism of its treatment sensitivity, modern surgical techniques, chemotherapy regimens, and treatment de-intensification protocols. We also discuss and reconsider potential adverse prognostic factors such as tumor EGFR expression, tumor hypoxia, and patient smoking history, as well as the significance of retropharyngeal adenopathy. Finally, we discuss elective nodal treatment of uninvolved lymph node stations. While this review does not exhaust all controversies related to the management of HPV+ OPC, it aims to highlight some of the most clinically relevant ones.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.